A Single-Center, Randomized, Double-Blind, Vehicle-Controlled Study to Assess the Activity of CRx-191 in Reducing the Psoriatic Infiltrate Band Thickness in Plaque Psoriasis

Trial Profile

A Single-Center, Randomized, Double-Blind, Vehicle-Controlled Study to Assess the Activity of CRx-191 in Reducing the Psoriatic Infiltrate Band Thickness in Plaque Psoriasis

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Jun 2014

At a glance

  • Drugs Mometasone/nortriptyline (Primary) ; Mometasone; Nortriptyline
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Zalicus
  • Most Recent Events

    • 24 Jun 2014 New source identified and integrated (European Clinical Trials Database; 2006-005848-87).
    • 24 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top